Abstract
A novel lotion formulation of fluticasone propionate 0.05% has recently become available. Two large, randomized, placebo-controlled, double-blind studies involving 438 subjects demonstrated its efficacy and safety when applied once daily in the treatment of atopic dermatitis in subjects from 3 months to 87 years of age. The studies were limited to 4 weeks duration of use of fluticasone lotion and did not assess longer term efficacy or side effects.
Publication types
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Topical
-
Adolescent
-
Androstadienes / administration & dosage*
-
Androstadienes / adverse effects
-
Anti-Allergic Agents / administration & dosage*
-
Anti-Allergic Agents / adverse effects
-
Child
-
Child, Preschool
-
Dermatitis, Atopic / drug therapy*
-
Dermatologic Agents / administration & dosage*
-
Dermatologic Agents / adverse effects
-
Double-Blind Method
-
Fluticasone
-
Humans
-
Infant
-
Ointments
Substances
-
Androstadienes
-
Anti-Allergic Agents
-
Dermatologic Agents
-
Ointments
-
Fluticasone